A humanized eNAMPT -neutralizing monoclonal antibody reduces cancer-induced bone pain and osteoclastogenesis in murine breast cancer model.
Journal: Frontiers in pain research (Lausanne, Switzerland)
•
Abstract
Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.
Subjects & Keywords
How to Cite this Article
Mathur NC, Villaroel E, Villaroel I, et al. (2026). "A humanized eNAMPT -neutralizing monoclonal antibody reduces cancer-induced bone pain and osteoclastogenesis in murine breast cancer model.". Frontiers in pain research (Lausanne, Switzerland). https://doi.org/10.3389/fpain.2026.1955262